Direct costs of bipolar disorder versus other chronic conditions: An employer-based health plan analysis

Psychiatric Services

Volumn 62, Issue 9, 2011, Pages 1073-1078

  Williams, Mark D ^a   Shah, Nilay D ^a   Wagie, Amy E ^a   Wood, Douglas L ^a   Frye, Mark A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; BIPOLAR DISORDER; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DEPRESSION; DIABETES MELLITUS; DRUG COST; EMPLOYER; FEMALE; GENDER; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL CARE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; OUTPATIENT CARE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY;

EID: 80054831147     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.62.9.pss6209_1073     Document Type: Article

References (16)

1. Merikangas KR, Akiskal HS, Angst J, et al: Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry 64:543-552, 2007 (Pubitemid 46718287)
2. Wyatt RJ, Henter I: An economic evaluation of manic-depressive illness - 1991. Social Psychiatry and Psychiatric Epidemiology 30:213-219, 1995
3. Rice DP, Miller LS: The economic burden of affective disorders. Advances in Health Economics and Health Services Research 14:37-53, 1993
4. Goetzel RZ, Hawkins K, Ozminkowski RJ, et al: The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large US employers in 1999. Journal of Occupational and Environmental Medicine 45:5-14, 2003 (Pubitemid 36091516)
5. Brook RA, Rajagopalan K, Kleinman NL, et al: Incurring greater health care costs: risk stratification of employees with bipolar disorder. Primary Care Companion to the Journal of Clinical Psychiatry 8:17-24, 2006 (Pubitemid 44371596)
6. Gardner HH, Kleinman NL, Brook RA, et al: The economic impact of bipolar disorder in an employed population from an employer perspective. Journal of Clinical Psychiatry 67:1209-1218, 2006 (Pubitemid 44439692)
7. Simon GE, Unützer J: Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatric Services 50:1303-1308, 1999 (Pubitemid 29468533)
8. Manning WG, Mullahy J: Estimating log models: to transform or not to transform? Journal of Health Economics 20:461-494, 2001 (Pubitemid 32515166)
9. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 45:613-619, 1992
10. Frye MA, Ketter TA, Leverich GS, et al: The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. Journal of Clinical Psychiatry 61:9-15, 2000 (Pubitemid 30104377)
11. Busch AB, Frank RG, Sachs G: Bipolar-I depression outpatient treatment quality and costs in usual care practice. Psychopharmacology Bulletin 41:24-39, 2008
12. Hollingsworth JM, Saint S, Hayward R, et al: Specialty care and the patient-centered medical home. Medical Care 49:4-9, 2011
13. Unützer J, Katon WJ, Fan MY, et al: Longterm cost effects of collaborative care for late-life depression. American Journal of Managed Care 14:95-100, 2008 (Pubitemid 351312092)
14. Bauer MS, McBride L, Williford WO, et al.: Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatric Services 57:937-945, 2006 (Pubitemid 44036223)
15. Williams M, Jaekels N, Rummans T, et al: Creating value in depression management. Quality in Primary Care 18:327-333, 2010
16. Schneiderhan ME, Batscha CL, Rosen C: Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy 29:975-987, 2009